Skip to main content
DrugPrice

Flolan

Epoprostenol

Generic availablePulmonary Hypertensionby GlaxoSmithKline
$19,167.00
avg cost per claim
-4.8% year-over-year
$345.0M
Medicare Spending
18,000
Total Claims
2,100
Beneficiaries
$164,286.00
Annual Cost/Patient

Why Flolan Costs $19,167.00 Per Claim

Flolan (Epoprostenol) is used to treat pulmonary hypertension. According to CMS Medicare Part D spending data, the program spent $345.0M on this drug, covering 2,100 beneficiaries across 18,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Epoprostenol or talk to their doctor about therapeutic alternatives that may cost less.

Price Breakdown

Avg cost per claim (30-day)$19,167.00
Avg annual cost per patient$164,286.00
Total Medicare spending$345.0M
Total claims18,000
Beneficiaries2,100

Drug Details

Brand Name
Flolan
Generic Name
Epoprostenol
Active Ingredient
Epoprostenol
Manufacturer
GlaxoSmithKline
Dosage Form
N/A
Route
N/A
Condition
Pulmonary Hypertension
FDA Application
BLA125057

Frequently Asked Questions

Flolan (Epoprostenol) costs an average of $19,167.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $164,286.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Flolan (Epoprostenol) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Epoprostenol.

Medicare Part D spent $345.0M on Flolan, covering 2,100 beneficiaries across 18,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Epoprostenol, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.